Dark

AXSM
Axsome Therapeutics, Inc
stock NASDAQ

At Close

Jul 31, 2026 3:59:55 PM EDT

217.68USD-7.240%(-16.99)781,964

209.88Bid 230.66Ask 20.78Spread

Pre-market

Jul 27, 2026 9:28:30 AM EDT

241.01USD+5.976%(+13.59)0

After-hours

Jul 31, 2026 4:00:30 PM EDT

217.99USD+0.142%(+0.31)82,877

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

11.22B

CEO

Herriot Tabuteau

Headquarters

New York, USA

Industry

Biotechnology

Next Earnings

Aug 10, 2026 (10d)

PDLI PIRS XLV

AXSM Stats

Avg. Vol. 10 Day

667,362

Avg. Vol. 30 Day

1,040,825

Employees

Market Cap

11,216,170,597

Shares Out.

51,459,766

On/Off Exchange

54%/46%

6 Month Beta

0.95

1 Year Beta

0.64

2 Year Beta

0.68

3 Year Beta

0.71

52 Week Low

96.09

52 Week High

260.19

SMA50

238.77

SMA200

184.73

1 Week

-9.56%

1 Month

-9.43%

3 Month

+5.53%

6 Month

+18.30%

1 Year

+114.99%

2 Year

+149.64%

5 Year

+348.57%

Profile

axsome therapeutics is a biopharmaceutical company developing novel therapies for the treatment of cns disorders. axsome has a balanced portfolio of clinical development stage as well as research stage product candidates. the company is based in new york city.

AXSM Stock Summary

Axsome Therapeutics, Inc (NASDAQ:AXSM) stock price today is $217.68, and today's volume is 781,964. AXSM is down -7.240% today. The 30 day average volume is 1,040,825. AXSM market cap is 11.22B with 51,459,766 shares outstanding.

.dark-mode .HQv5Lm{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .HQv5Lm{ color: #333333; background-color: white; border: 2px solid #333333; }AXSMAxsome Therapeutics, Incstock NASDAQ

AXSM Stock Summary

AXSM
Axsome Therapeutics, Inc
stock NASDAQ